Clinical Trials
Two clinical trials currently are open:
Funded through a four-year, $8 million grant from the California Institute for Regenerative Medicine, UCSF Alpha Stem Cell Clinic aims to accelerate the development and delivery of stem cell therapies to patients through high-quality clinical trials.
FDA-approved gene therapy/gene editing therapies
LYFGENIA - the longest-studied approved gene therapy for sickle cell disease
CASGEVY - a gene therapy that is made by editing the BCL11A gene
Learn more about our Gene Therapy team.
Alpha Stem Cell Clinic Information
